A randomized trial of low-dose rectal diclofenac for prevention of post endoscopic retrograde cholangiopancreatography pancreatitis
Not Applicable
- Conditions
- Post-ERCP pancreatitis
- Registration Number
- JPRN-UMIN000004658
- Lead Sponsor
- Saga Prefectural Hospital KOSEIKA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 230
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with acute or chronic pancreatitis. Patients with a history of endoscopic sphincterotomy. Patients who are diagnosed peptic ulcer disease. Patients with a history of aspirin-induced asthma. Patients with rectal diseases. Patients who are treated with triamterene. Pregnant and breast-feeding women. Patients who had taken NSAIDs during preceding week. Patients with a history of hypersensitivity to NSAIDs. Patients with a severe renal dysfunction.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The occurrence of PEP as defined by the criteria of Cotton as the development of abdominal pain and elevation of serum amylase level greater than three times the upper normal limit within 24 hours after ERCP
- Secondary Outcome Measures
Name Time Method